China and the US enter the new year lists with 'tit-for-tat' trade jousts
Setting the stage for the return of Donald Trump to the White House, China and ...
With the US-China tariff war showing every sign of worsening, multinational firms are considering building independent supply chains for the US and China.
Leading pharmaceutical company AstraZeneca has announced plans to establish manufacturing plants in China to serve the region exclusively.
For China-focused forwarders, the news represents a beacon of hope that the logistics industry may be shielded from the worst of the tariff and tension fallout.
A spokesperson from Dimerco told The Loadstar the move by AstraZeneca demonstrated companies’ faith in China’s self-sufficient ...
Volcanic disruption at Anchorage could hit transpacific airfreight operations
Macron calls for ‘suspension’ – CMA CGM's $20bn US investment in doubt
Trump tariffs see hundreds of cancelled container bookings a day from Asia
De minimis exemption on shipments from China to the US will end in May
Forwarders stay cool as US 'liberation day' tariffs threaten 'global trade war'
Mixed response in US to 'Liberation Day', while China leads wave of retaliation
Tariffs and de minimis set air freight rates on a volatile course
Overcapacity looms for ocean trades – with more blanked sailings inevitable
Comment on this article